Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Products > Anticorps > Anticorps pour Cytométrie en Flux

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B) (HW338107)

Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)
Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)
Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)
Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)
Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)
Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)
Prix(USD) :
Spécification :
  • 50ug
  • 100ug
Nombre :
Contactez-nous
  • Aperçu

  • Images

  • Reférences

  • Fiche technique

  • SDS

Aperçu
Numéro de catalogueHW338107
Reactivité des espècesHuman
ApplicationsFCM
Espèce hôteMouse
ClonalitéMonoclonal
IsotypeIgG2a, kappa
ID de clone1121B
Applications testées FCM
Cible CD309, EC:2.7.10.1, FLK-1, FLK1, Fetal liver kinase 1, KDR, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1, VEGFR-2, VEGFR2, Vascular endothelial growth factor receptor 2
Niveau d'endotoxines < 10 EU/mg
Pureté >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Numéro d'accès P35968
Forme Liquid
Tampon de stockage 0.01M PBS pH 7.4.

Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.

Stabilité et stockage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Contexte

Vascular endothelial growth factor receptor 2 (CD309/VEGFR-2) is a ~151 kDa protein. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. CD309 is the therapeutic target of ramucirumab (Cyramza).

Note For research use only.
Images
  • Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)

    Bioactivity

    SEC-HPLC detection for Anti-Human CD309/KDR/VEGFR-2 Antibody (1121B).

  • Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)

    Flow Cytometry

    Flow-cytometry using anti-human CD309 antibody.CD309 Transfected CHO cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human CD309 antibody monoclonal antibody (Catalog # HW338107 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-mouse antibody (Catalog # MF690414) and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human VEGFR2/KDR/Flk-1 Recombinant Antibody (1121B)

    Flow Cytometry

    Flow-cytometry using anti-human CD309 antibody.HUVEC cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human CD309 antibody monoclonal antibody (Catalog # HW338107 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-mouse antibody (Catalog # MF690414) and cells analysed on a NovoCyte Flow Cytometer.

Reférences
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommandation

Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.

Courrier : [email protected]

Liste des distributeurs